149 heavily shorted stocks rated Buy or better (Nov 2026)
149 heavily shorted stocks rated Buy or better by the Lician Quant rating as of Nov 4, 2026, including Coca-Cola Consolidated Inc. (COKE), Chime Financial, Inc. Class A Common Stock (CHYM), Immunitybio Inc (IBRX). Short interest of 10% of float or more at the latest FINRA settlement, while the quant rating is Buy or Strong Buy: where short sellers and the factors disagree.
Open this screen in the full screener to add filters, sort by any factor and save it.
149 stocks · Strong Buy or Buy · Short ≥ 10% of float
| Stock | Quant ratingRating | ValuationVal | GrowthGrow | ProfitabilityProf | MomentumMom | EPS revisionsRev | Market capMkt cap | P/EP/E | Revenue growthRev YoY | Div. yieldYield | Short % floatShort | Next earningsEarnings |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1BCYCBicycle Therapeutics Ltd | 4.04Buy | B+ | A+ | D+ | D | A- | $257M | NM | +194.7% | — | 183.3% | — |
| 2CLBKColumbia Financial Inc | 4.35Buy | B | B+ | F | A- | A- | $1.1B | 19.8 | +5.5% | — | 85.4% | — |
| 3MAZEMaze Therapeutics, Inc. Common Stock | 3.65Buy | D+ | — | C- | B | A- | $1.7B | NM | — | — | 78.2% | Nov 5 |
| 4CHYMChime Financial, Inc. Class A Common Stock | 3.82Buy | D- | — | C- | A | A | $9.9B | NM | — | — | 66.2% | Nov 4 |
| 5WLFCWillis Lease Finance Corporation | 4.48Buy | A+ | B+ | B- | F | B+ | $260M | 2.8 | +17.3% | — | 65.9% | — |
| 6GRNDGrindr Inc | 3.96Buy | C | A+ | A+ | D | C- | $2.2B | 23.0 | +32.4% | — | 64.7% | Nov 5 |
| 7BKNGBooking Holdings Inc | 4.64Strong Buy | A | B+ | A+ | D- | B- | $5.0B | — | +12.9% | — | 57.9% | — |
| 8QTTBQ32 Bio Inc | 5.00Strong Buy | A+ | — | A+ | B | A | $206M | 6.1 | — | — | 57.9% | Nov 12 |
| 9CVNACarvana Co | 4.93Strong Buy | A | A+ | B- | B- | B+ | $8.0B | 5.1 | +54.0% | — | 50.9% | — |
| 10TOYOTOYO Co., Ltd Ordinary Shares | 4.44Buy | A+ | A | B- | D- | — | $182M | 4.6 | +141.5% | — | 50.4% | Nov 18 |
| 11CLMBClimb Global Solutions | 4.24Buy | B+ | B | C- | A+ | D | $613M | 29.8 | +23.1% | — | 36.0% | — |
| 12COKECoca-Cola Consolidated Inc. | 4.43Buy | D | A- | B+ | A- | — | $12.0B | 21.9 | +10.7% | 0.57% | 34.3% | Nov 4 |
| 13IBRXImmunitybio Inc | 3.52Buy | F | A+ | D | B- | A | $8.7B | NM | +192.9% | — | 31.2% | — |
| 14FTKFlotek Industries Inc | 4.20Buy | F | A+ | B+ | C | A | $918M | 24.2 | +36.8% | — | 29.9% | — |
| 15DAVEDave Inc | 4.96Strong Buy | — | A+ | A+ | C | — | — | — | +48.6% | — | 28.2% | Nov 4 |
| 16CBRLCracker Barrel Old Country Store | 3.89Buy | D+ | D+ | D+ | A+ | A+ | $1.5B | 46.5 | -4.7% | 3.03% | 26.9% | Dec 8 |
| 17SGRYSurgery Partners Inc | 4.30Buy | A- | D+ | B | A- | B- | $3.0B | NM | +4.0% | — | 26.4% | Nov 9 |
| 18LQDALiquidia Technologies Inc | 4.15Buy | B | A+ | A+ | C | F | $3.8B | 27.4 | +2,234% | — | 26.1% | — |
| 19GRDNGuardian Pharmacy Services, Inc. | 4.73Strong Buy | A+ | — | B | C+ | B | $359M | 5.4 | +10.3% | — | 26.1% | Nov 5 |
| 20CAKEThe Cheesecake Factory | 4.33Buy | D- | B- | B- | A- | A+ | $5.3B | 29.5 | +5.7% | — | 25.9% | — |
| 21EVEREverQuote Inc Class A | 4.75Strong Buy | B+ | A+ | A+ | A+ | D | $692M | 6.0 | +22.7% | — | 25.2% | — |
| 22PATHUipath Inc | 4.79Strong Buy | A- | A- | A- | C+ | B- | $6.0B | 16.6 | +15.0% | — | 24.4% | Dec 2 |
| 23GRALGRAIL, LLC | 4.48Buy | D+ | A- | D+ | A | A+ | $5.6B | NM | +23.1% | — | 24.4% | Nov 4 |
| 24ARQTArcutis Biotherapeutics Inc | 4.92Strong Buy | C+ | A+ | A- | A- | B+ | $3.9B | 137.4 | +76.1% | — | 23.9% | Nov 4 |
| 25EZPWEZCORP Inc | 4.24Buy | B | A | C+ | D+ | B | $1.7B | 10.6 | +28.6% | — | 23.1% | Nov 12 |
Source: Lician Quant Grades (SEC EDGAR statements, EODHD prices and estimates); short interest: FINRA; earnings dates: earnings calendar; dividend yield: EODHD fundamentals · Quant run Nov 4, 2026
Grades rank each stock against its sector peers; they are not investment advice. How the rating and grades work · Short interest · Earnings calendar
Heavily shorted, rated Buy by sector
About this screen
- Which are the top heavily shorted stocks rated Buy or better?
- As of Nov 4, 2026, the highest ranked are Bicycle Therapeutics Ltd (BCYC, rating 4.04); Columbia Financial Inc (CLBK, rating 4.35); Maze Therapeutics, Inc. Common Stock (MAZE, rating 3.65); Chime Financial, Inc. Class A Common Stock (CHYM, rating 3.82); Willis Lease Finance Corporation (WLFC, rating 4.48). 149 stocks pass the screen in total.
- What does this screen look for?
- Short interest of 10% of float or more at the latest FINRA settlement, while the quant rating is Buy or Strong Buy: where short sellers and the factors disagree.
- How is the Lician Quant rating calculated?
- Each stock gets five factor grades (Valuation, Growth, Profitability, Momentum, EPS Revisions) from A+ to F by ranking its metrics against the other stocks in its sector. The rating (1.00 to 5.00) is the equal-weight average of the factor scores, re-ranked within the sector: 4.50 and up is Strong Buy, 3.50 Buy, 2.50 Hold, 1.50 Sell, below that Strong Sell.
- How often is the list updated?
- After every US trading day, from SEC filings, EODHD prices and analyst estimates; this list is from the quant run of Nov 4, 2026. Short interest follows FINRA's twice-monthly settlement dates.